KLCMEDIUM SIGNALFINANCIAL10-K

KLC shows mixed financial performance with substantially higher current assets but declining profitability and reduced stockholders' equity.

The company's liquidity position has meaningfully improved with current assets growing substantially, which provides greater financial flexibility. However, the deterioration in net losses combined with declining stockholders' equity suggests ongoing operational challenges that warrant investor attention.

Comparing 2026-03-13 vs 2025-03-21View on EDGAR →
FINANCIAL ANALYSIS

KLC's balance sheet shows a notably stronger liquidity position with current assets substantially higher at $358.0M, while current liabilities increased more modestly to $484.9M. The income statement reflects mixed results, with SG&A expenses declining meaningfully by 29.7% to $297.2M, though this cost reduction was insufficient to prevent net losses from worsening to $112.9M. The 12.6% decline in stockholders' equity to $755.3M indicates the company's financial foundation has weakened despite improved liquidity metrics.

FINANCIAL STATEMENT CHANGES
Current Assets
Balance Sheet
+66.7%
$214.8M$358.0M

Current assets grew 66.7% — improving short-term liquidity or inventory/receivables build.

SG&A Expense
P&L
-29.7%
$423.1M$297.2M

SG&A reduced 29.7% — improved cost efficiency or headcount reduction improving operating margins.

Net Income
P&L
-21.6%
-$92.8M-$112.9M

Net income declined 21.6% — review whether driven by operations, interest costs, or non-recurring items.

Current Liabilities
Balance Sheet
+17.5%
$412.8M$484.9M

Current liabilities rose 17.5% — increased short-term obligations, watch current ratio.

Accounts Receivable
Balance Sheet
+13.6%
$104.3M$118.5M

Receivables grew 13.6% — monitor days sales outstanding for collection efficiency.

Stockholders Equity
Balance Sheet
-12.6%
$864.5M$755.3M

Equity decreased 12.6% — buybacks or losses reducing book value, monitor solvency ratios.

LANGUAGE CHANGES
NEW — 2026-03-13
PRIOR — 2025-03-21
ADDED
The Proxy Statement will be filed with the Securities and Exchange Commission within 120 days of the registrant's fiscal year ended January 3, 2026 .
All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements.
Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance.
ii Summary of Risk Factors Below is a summary of the material factors that make an investment in our common stock speculative or risky.
A discussion of the risks summarized in this Summary of Risk Factors section can be found below under Part I, Item 1A.
+7 more — sign up free →
REMOVED
The registrant s common stock began trading on the New York Stock Exchange on October 9, 2024.
The Proxy Statement will be filed with the Securities and Exchange Commission within 120 days of the registrant's fiscal year ended December 28, 2024.
The information disclosed by the foregoing channels could be deemed to be material information.
ii Summary Risk Factors We are subject to a number of risks, including risks that may prevent us from achieving our business objectives or that may adversely affect our business, financial condition and results of operations.
You should carefully consider the risks discussed in the section titled Risk Factors, including the following risks, before investing in shares of our common stock: Risks Related to our Business Changes in the demand for child care and workplace solutions, which may be negatively affected by demographic trends and economic conditions, including unemployment rates, may materially and adversely affect our business, financial condition and results of operations.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →